| 英文别名 |
Pyrazolo[1,5-a]pyrimidine-3-carboxamide, N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-;Zasocitinib;CHEMBL5314423;Zasocitinib [WHO-DD];MS-28444;Pyrazolo(1,5-a)pyrimidine-3-carboxamide, N-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo(1(2H),2'-bipyridin)-3-yl)amino)-;N-((1R,2R)-2-methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-[1,2 inverted exclamation marka-bipyridin]-3-yl)amino)pyrazolo[1,5-a]-pyrimidine-3-carboxamide;2272904-53-5;compound I-908 [US20190256519A1];D12941;Zasocitinib (NDI-034858);TAK-279;SCHEMBL20678921;C293MNS6TQ;DA-56074;zasocitinib [INN];NDI-034858, Zasocitinib;US10508120, Compound I-816;N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-ylpyridin-3-yl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide;NDI034858;EX-A7221;Zasocitinib (USAN/INN);GTPL12155;NDI-034858;CS-0609920;TAK279;GLXC-27289;HY-150096;(8S)-N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-{[(1P,2'P)-2-oxo-2H-[1,2'-bipyridin]-3-yl]amino}pyrazolo[1,5-a]pyrimidine-3-carboxamide;UNII-C293MNS6TQ;N-((1R,2R)-2-Methoxycyclobutyl)-7-(methylamino)-5-((2-oxo-2H-[1,2'-bipyridin]-3-yl)amino)pyrazolo[1,5-a]pyrimidine-3-carboxamide;NDI-034858(Zasocitinib)?;N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5- [(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5- a]pyrimidine-3-carboxamide;US10508120, Compound I-908;BDBM424361;ZSB;F96153 |
关注我们
热线：
15806766175
COA质检证书
